AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitalembic M 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitalembic M 50mg/1000mg Tablet

Duo-Med 50mg/1000mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Duo-Med may be prescribed independently or in conjunction with other anti-diabetic therapies. Optimal results require adherence to a healthy diet and regular physical activity. Dosage is individualized based on your health status, blood glucose readings, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under your physician's guidance. Maintaining your prescribed diet and exercise regimen is crucial for successful diabetes control; lifestyle significantly influences management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential risk, particularly when used with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't universally suitable. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or lactating individuals should also seek medical advice. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor renal function and blood sugar levels throughout treatment.

Uses of Sitalembic M 50mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Sitalembic M 50mg/1000mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitalembic M 50mg/1000mg tablet whole; do not chew, crush, or divide it. Administer this medication with food.

Common Side effects of Sitalembic M 50mg/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalembic M 50mg/1000mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Sitalembic M 50mg/1000mg tablets should be administered with a meal.

How Sitalembic M 50mg/1000mg Tablet works:

Sitalembic M 50mg/1000mg tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances the body's insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action achieves superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitalembic M 50mg/1000mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitalembic M 50mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitalembic M 50mg/1000mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Operating a vehicle could be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitalembic M 50mg/1000mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Use of Sitalembic M 50mg/1000mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitalembic M 50mg/1000mg Tablet :

Should you forget a Sitalembic M 50mg/1000mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalembic M 50mg/1000mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Sitalembic M 50mg/1000mg Tablet

Sitalembic M 50mg/1000mg tablets contain sitagliptin and metformin, and are indicated for adult patients with type 2 diabetes. This dual-therapy medication helps regulate blood sugar when combined with a healthy diet and regular physical activity. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin's mechanism involves DPP4 enzyme inhibition, thereby boosting pancreatic insulin secretion. This formulation is contraindicated in individuals under 18.
Indeed, prolonged use of Sitalembic M 50mg/1000mg tablets can lead to vitamin B12 deficiency. This medication disrupts vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency can result in anemia and neurological complications, manifesting as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Prophylactic vitamin B12 supplementation, at least annually, is recommended by some investigators to mitigate these risks.
Sitalembic M 50mg/1000mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitalembic M 50mg/1000mg Tablet constituents or inactive ingredients should not use this medication. Its administration is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitalembic M 50mg/1000mg Tablet is unsafe due to a heightened risk of lactic acidosis.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Sitalembic M 50mg/1000mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction necessitates caution in patients with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia warrant immediate cessation of Sitagliptin + Metformin and prompt medical attention.
Sitalembic M 50mg/1000mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes in adults. This medication enhances glycemic control when coupled with a healthy diet and exercise regimen. Metformin reduces hepatic glucose output and improves insulin responsiveness, while sitagliptin's DPP-4 inhibition promotes increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalembic M 50mg/1000mg tablets may cause frequent side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may also occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalembic M 50mg/1000mg Tablet constituent or inactive ingredient should not take this medication. Similarly, its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 50mg/1000mg tablets with alcohol is unsafe due to the heightened risk of lactic acidosis.
Sitalembic M 50mg/1000mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is a rare but significant complication of metformin use, prompting its contraindication in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms might include muscular discomfort or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Sitalembic M and seek immediate medical attention.
Prolonged Sitalembic M 50mg/1000mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia and neurological complications, including peripheral paresthesia (tingling and numbness in the extremities), weakness, urinary dysfunction, cognitive changes, and gait instability (ataxia). To mitigate these risks, supplemental Vitamin B12 administration, at least annually, is recommended by some experts.
Store the medication in its original, tightly sealed container or packaging. Follow the storage instructions provided on the label or packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Sitalembic M 50mg/1000mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes in adults. This medication aids in blood sugar control when combined with a healthy diet and physical activity. Metformin reduces hepatic glucose output and enhances insulin sensitivity. Sitagliptin's mechanism involves DPP-4 enzyme inhibition, stimulating increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18 years of age.
Sitalembic M 50mg/1000mg tablets may cause common adverse events including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may occur. Prolonged treatment may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalembic M 50mg/1000mg Tablet ingredient or excipient should not use this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 50mg/1000mg tablets with alcohol is unsafe due to a heightened risk of lactic acidosis.
Sitalembic M 50mg/1000mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare adverse effect necessitates caution in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms may involve muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitalembic M and seek immediate medical attention.
Prolonged Sitalembic M 50mg/1000mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption in the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia and neurological complications, including peripheral neuropathy (tingling and numbness in extremities), muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive measures, as proposed by some studies, include annual supplemental Vitamin B12.
Store this medication in its original, tightly sealed container or packaging, following the storage guidelines provided on the label. Discard any leftover medication. Prevent access by children, pets, and others.
Sitalembic M 50mg/1000mg ...
149
MRP 173
13% off